Dmitry Balyasny’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
GA
Dmitry Balyasny's TMCI Position: Q3 2026 in Review
Dmitry Balyasny opened a new position in Treace Medical Concepts (TMCI) in Q3 2026: 18,603 shares worth $82.6K. The stake represents ﹤0.01% of the portfolio and ranks #2913 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in TMCI as recently as Q1 2025.
Dmitry Balyasny first reported a position in TMCI in Q1 2022 and has held it in 7 quarters since. The position peaked at $1.17M in Q3 2024. 116 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.
- Dmitry Balyasny held 18,603 shares of Treace Medical Concepts worth $82.6K as of Q3 2026.
- Treace Medical Concepts was a new Dmitry Balyasny position in Q3 2026.
- Treace Medical Concepts made up ﹤0.01% of Dmitry Balyasny's portfolio in Q3 2026, its #2913 holding.
- Dmitry Balyasny first reported a position in Treace Medical Concepts in Q1 2022 and has held it in 7 quarters since.
- Dmitry Balyasny's Treace Medical Concepts position peaked at $1.17M in Q3 2024.
- 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.